Skip to content
Awesome – Lifestyle
Author:
Cardinal Infrastructure Group Inc.
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
April 29, 2026
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026
April 13, 2026
Cardinal Infrastructure Group Awarded Contract for Large-Scale Data Center Campus Development
April 9, 2026
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
March 27, 2026
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
March 26, 2026
Cardinal Infrastructure Group Announces Appointment of Erik West as President of the Carolinas
March 20, 2026
Cardinal Infrastructure Group to be Added to the Russell 2000® and 3000® Indexes
March 20, 2026
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
March 19, 2026
Cardinal Infrastructure Group Inc. Announces Full Year 2025 Results and Affirms 2026 Guidance
March 19, 2026
Cardinal Infrastructure Group Schedules Full Year 2025 Earnings Conference Call
March 10, 2026
←
Previous Page
1
2
3
Next Page
→